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Abstract: 20 
Objectives: Co-infection of Middle East Respiratory Syndrome (MERS-CoV) with tuberculosis 21 
had not been previously reported.  Here, we present two cases with both MERS-COV and 22 
pulmonary tuberculosis.   23 
Methods: A case series of two cases with MERS-COV and pulmonary tuberculosis.   24 
Results: The first case was a 13 year-old patient who was admitted with a two-month history of 25 
fever, weight loss, night sweats and cough.  The second patient was a 30 year old who had a 26 
four-week history of cough associated with shortness of breath and weight loss of 2 kg.  The two 27 
patients were diagnosed to have pulmonary tuberculosis and had had positive MERS-CoV.   28 
Both patients were discharged home to complete the therapy for tuberculosis.  It is likely that 29 
both patients had pulmonary TB initially as they had prolonged symptoms and then they 30 
developed MERS-COV infection.   31 
Conclusions: It is important to carefully evaluate suspected MERS-CoV patients for the 32 
presence of other infectious diseases such as tuberculosis especially if cohorting is done for 33 
suspected MERS to avoid nosocomial transmission.   34 
 35 
 36 
 37 
 38 
 39 
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Introduction: 40 
Middle East Respiratory Syndrome (MERS-CoV) was first discovered in Saudi Arabia in 2012 41 
[1].  As of Jan 26, 2017, a total of 1888 laboratory confirmed cases of MERS-CoV infection, 42 
including at least 670 related deaths have been reported to WHO [2].   The clinical presentations, 43 
diagnosis and laboratory findings were previously described [3].  As highlighted in previous 44 
studies, none of the presenting symptoms helped distinguish patient with MERS-CoV infection 45 
from the patient presenting with influenza like illness (ILI) [4,5].  Even with access to full viral 46 
panel on all ILI patients and with evidence of influenza virus as the etiology, MERS-CoV cannot 47 
be ruled out.   A previous study showed one of 5 patients with MERS-CoV had influenza co-48 
infection [6].  Investigation of the initially described 47 MERS-CoV patients showed no co-49 
infection with MERS-CoV as microbiological investigations excluded bacterial pathogens 50 
associated with community-acquired pneumonia [7].  Co-infection of MERS-CoV with other 51 
viruses such as influenza had been reported [8].   52 
From April 2014 to November 2016, 295 confirmed cases were admitted to Prince Mohamed 53 
Bin Abdulaziz Hospital (PMAH), a MERS-CoV designated hospital in the capital Riyadh [5].  54 
To our knowledge, co-infection of MERS-CoV and Mycobacterium tuberculosis was not 55 
reported previously.   Here, we present two cases of co-infection of MERS-CoV and pulmonary 56 
tuberculosis. 57 
Methods:  58 
Patient data:  We extracted the date of admission, gender, age, results/dates of MERS-CoV 59 
testing, and patients’ outcomes.  We included the initial laboratory data: White Blood Cell count 60 
(WBC) 10
9
 per liter, Hemoglobin (Hgb) grams/deciliter, Platelets 10
9
 per liter, Creatinine 61 
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micromoles per liter, Albumin gram per liter, Aspartate Aminotransferase (AST) units per liter, 62 
Alanine Aminotransferase (ALT) units per liter, and initial chest-X-ray (CXR) results.  The 63 
study complied with institutional ethical guidelines. 64 
MERS-CoV testing: Nasopharyngeal swabs were tested for MERS-CoV using real-time 65 
reverse-transcription polymerase chain reaction (RT-PCR) as described previously [7,9].  The 66 
test amplified both the upstream E protein (upE gene) and ORF1a.  A positive case is considered 67 
if both assays were positive and controls were negative, as described previously[7].  The 68 
specimens were submitted to and testing was carried out at the Saudi Ministry of Health MERS-69 
CoV regional laboratory.  70 
CASE 1: 71 
A 13 year-old girl was admitted with a two-month history of fever, weight loss, night sweats and 72 
cough.   She had a history of contact with pulmonary tuberculosis patient in the past.  Four days 73 
prior to her presentation, she had worsening respiratory symptom.  No history of contact with 74 
camels or MERS-CoV patient. 75 
On examination: she looked ill, cachectic, with respiratory distress.  She was febrile T: 39°C, 76 
BP: 100/59 RR 38 SPO2 95%; weight 40KG.  There was no lymphadenopathy.  Chest: bronchial 77 
breathing and crepitation bilaterally.   78 
Chest X-rays showed diffuse multi-nodular infiltration consistent with miliary TB (figure 1).  79 
CT-scan of chest and abdomen showed multiple pulmonary nodules randomly distributed in both 80 
lungs.  Multiple areas of consolidation especially within the left upper lobe were also noted.  81 
Bilateral upper lobes multiple cystic areas probably representing cystic bronchiectasis changes 82 
were seen. There were necrotic mediastinal and enlarged hilar lymph node.  83 
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A nasopharyngeal swab collected upon presentation was positive for MERS-CoV and negative 84 
for infuenza and a repeated swab after 48 Hrs was negative MERS-CoV.  A tuberculin skin test 85 
(TST) was 10 mm, and sputum AFB smears were negative, but gastric aspirate were positive for 86 
M .tuberculosis by PCR, mycobacterium culture was positive for M. tuberculosis.  During 87 
hospitalization, the patient had respiratory distress and hypoxia requiring intensive care (ICU) 88 
admission for observation. Isoniazid, ethambutol, pyrazinamoide and rifampicin were started.  89 
The patient was discharged home in stable condition after hospitalization for 3 weeks to 90 
complete anti-TB therapy.  91 
CASE 2  92 
A 30 year-old Filipino female nurse had unprotected exposure to a patient with MERS-CoV on 93 
May 15, 2015.  During that time, she was quarantined for 14 days in the hospital and two 94 
nasopharyngeal swabs for MERS-CoV were negative.  A month later, she went to the 95 
Philippines. Two weeks after her arrival to Philippines, she manifested symptoms of dry cough 96 
and shortness of breath, and she took amoxicillin with no improvement. On August 7, she 97 
returned to Saudi Arabia.  She was evaluated on August 12 for dry cough for 4 weeks, associated 98 
with shortness of breath associated with weight loss of 2 kg.  She had no history of contact with 99 
TB patient and no history of recent contact with MERS-COV patient. 100 
On examination, temperature 37 °C (Oral) BP: 133/88 SpO2: 94%; Chest examination revealed 101 
crepitation in the left upper lobe.  Laboratory data showed: WBC 6.8, neutrophil 68%, ESR 90, 102 
and CRP: 0.39. 103 
Chest x-ray showed non-homogenous opacity involving most of the left lung more prominent at 104 
the upper and middle left lung zones (figure 2). 105 
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A nasopharyngeal swab collected upon presentation was positive for MERS-CoV and negative 106 
for influenza. A repeated swab after 48Hrs was negative for MERS-CoV.  Sputum AFB PCR, 107 
AFB smear were positive but TB culture was negative.  She was treated with isoniazid, 108 
ethambutol, pyrazinamoide and rifampicin. 109 
Discussion: 110 
The presentation of these two patients is of particular interest due to the co-infection with 111 
MERS-CoV and pulmonary TB.  We are not aware of any previous such report.  Co-infection of 112 
MERS-CoV patients with influenza A, parainfluenza, herpes simplex, and Streptococcus 113 
pneumoniae, Herpes simplex virus type 1  and rhinovirus RNA14 were reported [8,10,11].  Co-114 
infection with M. tuberculosis is of particular importance as the diagnosis of TB might be 115 
overlooked and shadowed by the concern about MERS-CoV infection as occurred during the 116 
SARS outbreak [12].  One patient contracted SARS when she was cohorted with SARS patient 117 
although she initially had TB [12].  In another report, a healthcare worker had healthcare-118 
associated SARS infection and was diagnosed with pulmonary TB and two other patients were 119 
known to have pulmonary TB and had a superinfection with SARS-CoV after contact with other 120 
hospitalized SARS patients [13]. Another two patients had pulmonary TB after recovery from 121 
SARS [14].  In this report, the first patients was co-infected with MERS-CoV and pulmonary TB 122 
and might had been infected with both as the M. Tuberculosis culture was negative.  Both 123 
MERS-CoV and TB may cause immune suppression and augment the infection of each other as 124 
was described with SARS and TB [13].  It is important to carefully evaluate suspected MERS-125 
CoV for the presence of other infectious diseases such as TB especially if cohorting is done for 126 
suspected MERS to avoid nosocomial transmission of TB as was described with the SARS [15].  127 
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In the current cases it is likely that both patients had pulmonary TB initially as they had 128 
prolonged symptoms and then they developed MERS-COV infection.   129 
 130 
 131 
 132 
 133 
 134 
 135 
 136 
 137 
 138 
 139 
 140 
 141 
 142 
 143 
 144 
 145 
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Figure 1: Diffuse multi-nodular infiltration consistent with military tuberculosis 206 
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Figure 2: Chest X-ray showing a non-homogenous opacity involving most of the upper and 223 
middle left lung zones 224 
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